Pavel Printsev

Chief Business Development Officer at 3billion

Presenter

Pavel Printsev is the founding Chief Business Development Officer at 3billion, where he leads the AI-driven drug discovery division, shaping its development strategy and partnering initiatives. Prior to joining 3billion, he led global business development at Bridge Biotherapeutics. His career began in organic chemistry as a research scientist before expanding into venture capital, company building, BD and corporate strategy.

Throughout his career, Pavel has focused on advancing scientific innovation through global partnerships, collaborations, and cross-border deal-making, with a consistent emphasis on connecting Korean biotech platforms and assets with partners across North America, Europe, and Asia.